Ultralife CORP 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NASDAQ
Ultralife Corporation announced second quarter results showing a significant improvement in gross profit margin and adjusted EBITDA, alongside a record backlog of $117.5 million.
NASDAQ
Ultralife Corporation's 2026 Annual Meeting saw the election of five directors, ratification of auditors, and approval of executive compensation, with a preference for triennial advisory votes.
NASDAQ
Ultralife Corporation announced first quarter 2026 results showing a year-over-year decrease in sales and profitability, impacted by operational disruptions and weak Communications Systems sales, though backlog reached a record high.
NASDAQ
Ultralife Corporation reported a 21.5% revenue increase to $43.4 million in Q3 2025, but posted an operating loss of $1.0 million due to one-time costs and operational inefficiencies.
NASDAQ
Ultralife Corporation has appointed Withum Smith+Brown as its new independent registered public accounting firm, replacing Freed Maxick P.C. due to an acquisition.
NASDAQ
Ultralife Corporation reported a 13% increase in second-quarter sales to $48.6 million, driven by an acquisition, but faced significant declines in profitability and Communications Systems sales.
NASDAQ
Ultralife Corporation announced the successful election of its five directors and the ratification of Freed Maxick P.C. as its independent registered public accounting firm for 2025 at its 2025 Annual Meeting of Stockholders.
NASDAQ
Ultralife Corporation announced a 21% year-over-year revenue increase in its first quarter results, driven by growth in Battery & Energy Products.
NASDAQ
Ultralife Corporation's Q4 results show a slight revenue decrease year-over-year, impacted by communication systems sales decline and offset partially by the Electrochem acquisition.
NASDAQ
Ultralife Corporation has acquired Electrochem Solutions, Inc., and the associated financial statements have been released in an amended 8-K filing.
NASDAQ
Ultralife Corporation's third quarter results show a decrease in revenue and profit compared to the previous year, impacted by timing of orders and supply chain issues, but also includes a significant debt reduction and the acquisition of Electrochem Solutions, Inc.
NASDAQ
Ultralife Corporation has successfully acquired Electrochem Solutions, Inc. for $50 million in cash, expanding its reach in the battery technology market.
NASDAQ
Ultralife Corporation has agreed to acquire Electrochem Solutions, Inc. for $50 million in cash, aiming to enhance profitability through increased scale and margin expansion.
NASDAQ
Ultralife Corporation announced its second quarter results, highlighting record sales in its Battery & Energy Products segment and a significant reduction in debt.
NASDAQ
Ultralife Corporation held its 2024 Annual Meeting, electing five directors, ratifying its accounting firm, and approving a new long-term incentive plan.
NASDAQ
Ultralife Corporation announced a robust first quarter with significant revenue growth and improved profitability, driven by strong demand in the medical and government/defense sectors.
NASDAQ
Ultralife Corporation announced a significant increase in sales and profitability for the fourth quarter and full year 2023, driven by strong performance in both its Battery & Energy Products and Communications Systems segments.